Scientific and Planning Committee 7th GBHI Meeting
- Wenlei Jiang, PhD, Food and Drug Administration (FDA), US (co-chair)
- Kevin Blake, PhD, European Medicines Agency (EMA), The Netherlands (co-chair)
- Barbara S. Schug, PhD, SocraTec R&D GmbH, Germany
- Susana Almeida, PhD, Medicines for Europe, AISBL, Belgium
- Anne Seidlitz, Freie Universitaet Berlin, Berlin, Germany
- Erem Bilensoy, PhD, Hacettepe University, Turkey
- Jutta Walstab, PhD, SocraTec R&D, Germany
- Jack Cook, PhD, A2-Ai, US
- John Gordon, PhD, Health Canada, Canada
- Sebastian Haertter, PhD, Boehringer Ingelheim, Germany
- Georg Hempel, PhD, University of Münster, Germany
- Flora Musuamba Tshinanu, PhD, AFMPS - FAGG(EMA), Belgium
- Ryosuke Kuribayashi, PhD, Pharmaceuticals and Medical Devices Agency, Japan
- Mehul Mehta, PhD, Food and Drug Administration (FDA), US
- Carolien Versantvoort, PhD, MEB, The Netherlands
- Katalina Mettke, PhD, Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM), Germany
- Alfredo Garcia Arieta, PhD, AEMPS (EMA), Spain
- Paulo Paixão, PhD, Lisbon University, Member of the Medicines Evaluation Board at INFARMED, Portugal
- Nilufer Tampal, PhD, Food and Drug Administration (FDA), US
- Peter Caspers, PhD, MEB (EMA), The Netherlands
- Ralph-Steven Wedemeyer, PhD, SocraMetrics GmbH, Germany
- Jan Welink, PhD, Medicines Evaluation Board (MEB), Netherlands
- Erika Fredriksson, Lakemedelsverket (EMA), Sweden
- Andrew Cooper, Viatris, Portugal
- Elizabeth Collins, Viatris, UK
- Eduardo Agostinho Freitas Fernandes, Agência Nacional de Vigilância Sanitária (ANVISA), Brazil
